United States· US:48815-1001_c07d2306-68cc-4c33-9b6f-4750c0edf625
Sodium Iodide I 123
A medicinal product containing sodium iodide i-123, registered in United States by Cardinal Health 418, Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SODIUM IODIDE I-123
- Manufacturer
- Cardinal Health 418, Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1148815-1001-5
- ndc1148815-1001-1
- ndc1148815100111 VIAL, PLASTIC in 1 CAN (48815-1001-1) / 1 CAPSULE, GELATIN COATED in 1 VIAL, PLASTIC
- ndc1148815100151 VIAL, PLASTIC in 1 CAN (48815-1001-5) / 5 CAPSULE, GELATIN COATED in 1 VIAL, PLASTIC
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium iodide i-123 in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSODIUM IODIDE (I123) INJECTIONCurium Netherlands B.V., Petten
- BelgiumHippuran (I-123) 37 MBq/mlCurium Belgium
- United KingdomSodium iodide [I-123] 185MBq/5ml solution for injection vialsCurium Pharma UK Ltd
- Germany[123i] Sodium Iodide Injection Ge HealthcareGe Healthcare Buchler Gmbh & Co. Kg
- FranceIODURE (123 I) DE SODIUM CURIUMPHARMA 37 MBq/mL, solution injectableCURIUM NETHERLANDS (PAYS-BAS)
- SwitzerlandNatriumiodid (I-123), Diagnosekapselnmedeo AG
- SwedenNatriumjodid (I-123) Curiumpharma 37 MBq/ml Injektionsvätska, lösningCurium Netherlands B.V.
- CanadaSODIUM IODIDE I-123 ORAL SOLUTIONBWXT MEDICAL LTD.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Sodium Iodide (123i) Ge Healthcare, Sodium Iodide (I-123) Curium
- Czechia · Sodium Iodide (I123) Injection Curium Netherlands
- Germany · [123i] Sodium Iodide Injection Ge Healthcare, Sodium Iodide (I123) Injection Curium Netherlands
- Denmark · Sodium Iodide [123i] Ge Healthcare, Sodium Iodide I123
- Spain · Ioduro (123i) De Sodio Curium Pharma Spain, Ioduro (123i) De Sodio Ge Healthcare
- Finland · Natriumjodid (I-123) Curium Netherlands, Sodium Iodide (I-123) Curium Netherlands
- France · Iodure (123i) De Sodium Curiumpharma, Iodure (123i) De Sodium Ge Healthcare
- United Kingdom (Northern Ireland) · Sodium Iodide (123i) Injection Ge Healthcare Limited, Sodium Iodide (I-123) Curium Netherlands
- Hungary · [123i]-Nátrium-Jodid Curium Netherlands
- Italy · Sodio Ioduro (123i) Curium Netherlands, Sodio Ioduro (123i) Ge Healthcare
- Netherlands · [|1231] Sodium Iodide Ge Healthcare, [123i] Sodium Iodide Ge Healthcare
- Norway · Sodium Iodide (I123), Sodium Iodide [1231] Ge Healthcare
- Sweden · Natriumjodid (I-123) Curiumpharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/291152f4-0349-4654-b5fe-fa40a2290a1a GET /v1/drugs/291152f4-0349-4654-b5fe-fa40a2290a1a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "SODIUM IODIDE I-123",
"productndc": "48815-1001",
"dosage_form": "CAPSULE, GELATIN COATED",
"dea_schedule": null,
"strength_unit": "uCi/1",
"application_number": "NDA018671",
"marketing_category": "NDA"
}See everything about sodium iodide i-123.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.